Karen Nalbandyan
Karen Nalbandyan publishes mostly in Oncology, Pathology and Forensic Medicine and Surgery, on topics such as Lymphoma Diagnosis and Treatment, Viral-associated cancers and disorders and Cardiac tumors and thrombi.
- World rank
- #7,131,143 of 7,710,434 ranked researchers
- Rank in Israel
- #37,215 of 38,292
- Works
- 29
- Citations
- 244
- Citations per work
- 8.4
What does Karen Nalbandyan research?
Karen Nalbandyan's work is mostly in Medicine (48%), Biochemistry, Genetics and Molecular Biology (6%), Immunology and Microbiology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1447.5%
- Medicine1447.5%
- Everything else1241.5%
- Life Sciences311.0%
- 1Oncology21% of their works
- 2Pathology and Forensic Medicine12% of their works
- 3Surgery7% of their works
- 4Genetics7% of their works
- 5Molecular Biology6% of their works
- 6Immunology5% of their works
Research topics
Which keywords describe Karen Nalbandyan's research?
The keywords of their largest research topics: Rituximab, Classification, Lymphoma, Epstein-Barr Virus, Kaposi's Sarcoma, Angiosarcoma, Cardiac Tumors and Chronic Lymphocytic Leukemia.
- Sickle-cell Disease
- BET Bromodomains
- International Myeloma Working Group
- Epithelioid Hemangioendothelioma
- Chronic Lymphocytic Leukemia
- Angiosarcoma
- Epstein-Barr Virus
- Classification
- Rituximab
- Lymphoma
- Kaposi's Sarcoma
- Cardiac Tumors
- Diagnosis Criteria
- Genomic Aberrations
- PRKAR1A Gene Mutations
- PROTACs
- Thalassemia
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Rituximab112 topics
- Classification81 topic
- Lymphoma81 topic
- Epstein-Barr Virus71 topic
- Kaposi's Sarcoma71 topic
- Angiosarcoma31 topic
- Cardiac Tumors31 topic
- Chronic Lymphocytic Leukemia31 topic
- Diagnosis Criteria31 topic
- Epithelioid Hemangioendothelioma31 topic
- Genomic Aberrations31 topic
- International Myeloma Working Group31 topic
- PRKAR1A Gene Mutations31 topic
- BET Bromodomains21 topic
- PROTACs21 topic
- Sickle-cell Disease21 topic
- Thalassemia21 topic
Where does Karen Nalbandyan work?
Karen Nalbandyan's main affiliation in the publication record is Ben-Gurion University of the Negev, Israel.
How many publications and citations does Karen Nalbandyan have?
OpenAlex counts 29 works and 244 citations for Karen Nalbandyan, an h-index of 9, ranking #7,131,143 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Karen Nalbandyan. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.